Rose-Hellekant T A, Bavister B D
Department of Animal Health and Biomedical Sciences, University of Wisconsin-Madison 53706, USA.
Mol Reprod Dev. 1996 Jun;44(2):241-9. doi: 10.1002/(SICI)1098-2795(199606)44:2<241::AID-MRD14>3.0.CO;2-5.
Four hypotheses were tested using isolated bovine oocytes. (1) Cumulus oocyte complexes (COCs) or denuded oocytes (DOs) were cultured with the protein kinase A (PKA) inhibitor, H-89, to test if meiotic arrest induced by forskolin or IBMX was due to cAMP-stimulated PKA activity or nonspecific effects of these cAMP elevators. (2) COCs were cultured with a protein kinase C (PKC) stimulator (PDD beta) or inhibitor (GF109203x) to test if PKC modulation altered oocyte maturation. (3) COCs were prestimulated for 15 min with (a) PDD beta followed by cotreatment with forskolin, or (b) with H-89 or H-7 followed by cotreatment with GF109203x, to test for interaction between the PKA and PKC signal transduction pathways. (4) H-89 was added to spontaneously maturing COCs at intervals of 0-18 hr to test if H-89 interfered with the transition between meiosis I and II. The results were as follows: H-89 interfered with forskolin or IBMX arrested oocytes in dose-response manner (IBMX ED50 = 41 microM for COCs; forskolin ED50 = 9 microM for denuded oocytes). Prestimulation with PKC induced meiotic resumption in COCs in spite of the presence of forskolin [PDD beta followed by PDD beta + forskolin: 41-47% germinal vesicle (GV) oocytes; forskolin alone: 90-95% GV], while PKC inhibition induced meiotic arrest to a similar extent as forskolin (GF109203x, 85% GV; forskolin, 67-80% GV). Additionally, pretreatment of COCs with H-89 interfered with GF109203x induced arrest (41% vs. 90% GV, respectively). Finally, H-89 interfered with the timely progression of COCs from meiosis I and II. These results indicate that the PKA and PKC pathways can modulate the maturation of bovine oocytes in vitro.
使用分离的牛卵母细胞对四个假设进行了测试。(1)将卵丘卵母细胞复合体(COC)或裸卵(DO)与蛋白激酶A(PKA)抑制剂H-89一起培养,以测试由福斯高林或异丁基甲基黄嘌呤(IBMX)诱导的减数分裂阻滞是否归因于cAMP刺激的PKA活性或这些cAMP升高剂的非特异性作用。(2)将COC与蛋白激酶C(PKC)刺激剂(PDDβ)或抑制剂(GF109203x)一起培养,以测试PKC调节是否会改变卵母细胞成熟。(3)用(a)PDDβ预刺激COC 15分钟,然后与福斯高林共同处理,或(b)用H-89或H-7预刺激,然后与GF109203x共同处理,以测试PKA和PKC信号转导途径之间的相互作用。(4)以0至18小时的间隔将H-89添加到自发成熟的COC中,以测试H-89是否会干扰减数分裂I和II之间的转换。结果如下:H-89以剂量反应方式干扰福斯高林或IBMX阻滞的卵母细胞(对于COC,IBMX的半数有效剂量(ED50)= 41微摩尔;对于裸卵,福斯高林的ED50 = 9微摩尔)。尽管存在福斯高林,但用PKC预刺激仍可诱导COC中的减数分裂恢复[PDDβ接着PDDβ +福斯高林:41 - 47%的生发泡(GV)卵母细胞;单独使用福斯高林:90 - 95%的GV],而PKC抑制诱导的减数分裂阻滞程度与福斯高林相似(GF109203x,85%的GV;福斯高林,67 - 80%的GV)。此外,用H-89预处理COC会干扰GF109203x诱导的阻滞(分别为41%对90%的GV)。最后,H-89干扰了COC从减数分裂I到II的及时进展。这些结果表明,PKA和PKC途径可以在体外调节牛卵母细胞的成熟。